What is the official website of GrupoBios ?

The official website of GrupoBios is https://grupobios.cl/.

What is GrupoBios's cybersecurity risk score?

GrupoBios has an AI-generated cybersecurity risk score of 751 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has GrupoBios experienced?

According to Rankiteo, GrupoBios currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has GrupoBios been affected by any supply chain cyber incidents ?

According to Rankiteo, GrupoBios has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does GrupoBios have SOC 2 Type 1 certification ?

According to Rankiteo, GrupoBios is not certified under SOC 2 Type 1.

Does GrupoBios have SOC 2 Type 2 certification ?

According to Rankiteo, GrupoBios does not hold a SOC 2 Type 2 certification.

Does GrupoBios comply with GDPR ?

According to Rankiteo, GrupoBios is not listed as GDPR compliant.

Does GrupoBios have PCI DSS certification ?

According to Rankiteo, GrupoBios does not currently maintain PCI DSS compliance.

Does GrupoBios comply with HIPAA ?

According to Rankiteo, GrupoBios is not compliant with HIPAA regulations.

Does GrupoBios have ISO 27001 certification ?

According to Rankiteo,GrupoBios is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does GrupoBios operate in ?

GrupoBios operates primarily in the Biotechnology Research industry.

How many employees does GrupoBios have ?

GrupoBios employs approximately 153 people worldwide.

Does GrupoBios own any subsidiaries ?

GrupoBios presently has no subsidiaries across any sectors.

How many LinkedIn followers does GrupoBios have ?

GrupoBios's official LinkedIn profile has approximately 10,141 followers.

What is the NAICS classification code for GrupoBios ?

GrupoBios is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does GrupoBios have a Crunchbase profile ?

No, GrupoBios does not have a profile on Crunchbase.

Does GrupoBios have a LinkedIn profile ?

Yes, GrupoBios maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/grupobios.

How many cybersecurity incidents has GrupoBios experienced ?

As of August 17, 2026, Rankiteo reports that GrupoBios has not experienced any cybersecurity incidents.

How many peer or competitor companies does GrupoBios have ?

GrupoBios has an estimated 4,739 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

GrupoBios

Boost Score +25 with badge (5 left)

751

/1000

Fair

776

/1000

Fair

GrupoBios Vendor Cyber Rating & Cyber Score

grupobios.cl

Add Your Compliance Badge

Somos un equipo de trabajo competente, cohesionado y comprometido que busca innovar permanentemente. Porque también trabajamos en el laboratorio comprendemos la diferencia que los mejores insumos y equipos pueden hacer en el trabajo de un equipo humano de excelencia. Motivamos permanentemente a nuestros colaboradores a mantener su compromiso con el servicio, calidad y tecnología para exceder las expectativas de nuestros clientes. Lo más importante para nosotros es que nuestros clientes obtengan lo último en tecnología que les permita desarrollar mejor su trabajo. Por eso, llevamos más de 30 años dedicados al desarrollo, manufactura, distribución y comercialización de reactivos, insumos, equipamiento y soluciones informáticas para el

GrupoBios A.I CyberSecurity Scoring

Scoring History

GrupoBios

GrupoBios CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

GrupoBios Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for GrupoBios

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for GrupoBios in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for GrupoBios in 2026.

Incident Types GrupoBios vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for GrupoBios in 2026.

Incident History - GrupoBios (X = Date, Y = Severity)

Loading…

SUBSIDIARY

GrupoBios Subsidiaries

Parent Company

GrupoBios

Biotechnology Research

Website: https://grupobios.cl/

Company Size: 153

No subsidiary data available for this company.

Loading…

GrupoBios Similar Companies

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Loading…

NEWS

GrupoBios CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-19917

SUMMARY

A flaw has been found in code-projects Online Food Order System 1.0. The impacted element is an unknown function of the file delete_food_items1.php. Executing a manipulation of the argument checkbox can lead to sql injection. The attack can be executed remotely. The exploit has been published and may be used.

Published

Date2026-08-15

Updated

Date2026-08-15

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-74767

SUMMARY

Pandora contains a denial-of-service vulnerability in its handling of DAA (Direct Access Archive) files. When extracting the internal ISO image from a DAA archive, compressed chunks were decompressed using zlib.decompress() without enforcing a limit on the resulting uncompressed data. An attacker able to submit a crafted DAA file containing highly compressed data could cause Pandora to decompress a relatively small input into a very large amount of data in memory. Because the decompressed chunks are accumulated to construct the internal ISO image, this could result in excessive memory consumption and potentially CPU exhaustion, causing the extraction worker to become unresponsive, terminate, or affect the availability of the Pandora service. The patch introduces bounded decompression using decompressobj().decompress() with max_extracted_filesize, verifies the cumulative size of decompressed chunks, and raises a dedicated ZipBomb exception when the configured limit is exceeded. Pandora then aborts extraction and reports the file as too large.

Published

Date2026-08-15

Updated

Date2026-08-15

RISK INFORMATION (Score: )

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/pandora-analysis/pandora/commit/f4294a873f86fbf2569c289e329fff2f52ca50c9

CVE-2026-74764

SUMMARY

Pandora contains a path traversal vulnerability in its TAR archive extraction functionality. When processing a submitted TAR archive, the extractor passed archive member names directly to Python's tarfile.TarFile.extract() without applying an extraction filter. An attacker able to submit a specially crafted TAR archive containing malicious member paths, such as paths using ../ sequences or absolute paths, could cause extracted files to be written outside the intended extraction directory. This may allow the attacker to overwrite files accessible to the Pandora worker process and could potentially result in application compromise, arbitrary code execution, or denial of service depending on the files targeted and the privileges of the Pandora process. The vulnerability is corrected by using Python's filter='data' extraction filter, which rejects or sanitizes dangerous TAR members, including paths that escape the destination directory and unsafe link targets. The weakness corresponds to MITRE's general path traversal category, which includes archive extraction cases where attacker-controlled filenames cause files to be written outside the intended directory.

Published

Date2026-08-15

Updated

Date2026-08-15

RISK INFORMATION (Score: )

cvss4

Base Score: 10.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/pandora-analysis/pandora/commit/186b58d41e04248a154d274fffb5813e7fa2012e

CVE-2026-73055

SUMMARY

Shescape before 2.1.15 (and 3.0.0 before 3.0.2) fails to properly escape tilde (~) characters in assignment contexts on Unix systems where the shell is explicitly configured to "sh" or true and /bin/sh points to BusyBox. Using the escape and escapeAll APIs with untrusted input in an assignment prefixed to a command, an attacker can inject a tilde payload to disclose the user's home directory location and, depending on usage, alter the location on which a command operates.

Published

Date2026-08-15

Updated

Date2026-08-15

RISK INFORMATION (Score: 4.8)

cvss3

Base Score: 4.8

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:N

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.2

REFERENCES

CVE-2026-73054

SUMMARY

SiYuan versions before v3.7.4 contain an authentication bypass vulnerability in the WebSocket endpoint caused by differential parsing of query parameters between authentication exemption and session quarantine checks. Unauthenticated attackers can craft a malicious WebSocket URI with duplicated query parameters to bypass access auth code validation and receive the live kernel event stream including document identifiers, titles, and operation logs.

Published

Date2026-08-15

Updated

Date2026-08-15

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…